In another study, a contradictory role was reported for HMGA2—Li et al. showed that HMGA2 overexpression suppresses gefitinib resistance in NSCLC cells by inhibiting autophagy [185]. The gene discussed is HMGA2; the disease is non-small cell lung carcinoma.